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Abstract
Background: Trachoma is the world’s leading cause of infectious blindness. The World Health Organization (WHO) has
endorsed the SAFE strategy in order to eliminate blindness due to trachoma by 2020 through ‘‘surgery,’’ ‘‘antibiotics,’’ ‘‘facial
cleanliness,’’ and ‘‘environmental improvement.’’ While the S and A components have been widely implemented, evidence
and specific targets are lacking for the F and E components, of which water, sanitation, and hygiene (WASH) are critical
elements. Data on the impact of WASH on trachoma are needed to support policy and program recommendations. Our
objective was to systematically review the literature and conduct meta-analyses where possible to report the effects of
WASH conditions on trachoma and identify research gaps.
Methods and Findings: We systematically searched PubMed, Embase, ISI Web of Knowledge, MedCarib, Lilacs, REPIDISCA,
DESASTRES, and African Index Medicus databases through October 27, 2013 with no restrictions on language or year of
publication. Studies were eligible for inclusion if they reported a measure of the effect of WASH on trachoma, either active
disease indicated by observed signs of trachomatous inflammation or Chlamydia trachomatis infection diagnosed using PCR.
We identified 86 studies that reported a measure of the effect of WASH on trachoma. To evaluate study quality, we developed
a set of criteria derived from the GRADE methodology. Publication bias was assessed using funnel plots. If three or more
studies reportedmeasures of effect for a comparableWASH exposure and trachoma outcome, we conducted a random-effects
meta-analysis. We conducted 15 meta-analyses for specific exposure-outcome pairs. Access to sanitation was associated with
lower trachoma as measured by the presence of trachomatous inflammation-follicular or trachomatous inflammation-intense
(TF/TI) (odds ratio [OR] 0.85, 95% CI 0.75–0.95) and C. trachomatis infection (OR 0.67, 95% CI 0.55–0.78). Having a clean face was
significantly associated with reduced odds of TF/TI (OR 0.42, 95% CI 0.32–0.52), as were facial cleanliness indicators lack of
ocular discharge (OR 0.42, 95% CI 0.23–0.61) and lack of nasal discharge (OR 0.62, 95% CI 0.52–0.72). Facial cleanliness
indicators were also associated with reduced odds of C. trachomatis infection: lack of ocular discharge (OR 0.40, 95% CI 0.31–
0.49) and lack of nasal discharge (OR 0.56, 95% CI 0.37–0.76). Other hygiene factors found to be significantly associated with
reduced TF/TI included face washing at least once daily (OR 0.76, 95% CI 0.57–0.96), face washing at least twice daily (OR 0.85,
95% CI 0.80–0.90), soap use (OR 0.76, 95% CI 0.59–0.93), towel use (OR 0.65, 95% CI 0.53–0.78), and daily bathing practices (OR
0.76, 95% CI 0.53–0.99). Living within 1 km of a water source was not found to be significantly associated with TF/TI or C.
trachomatis infection, and the use of sanitation facilities was not found to be significantly associated with TF/TI.
Conclusions: We found strong evidence to support F and E components of the SAFE strategy. Though limitations included
moderate to high heterogenity, low study quality, and the lack of standard definitions, these findings support the
importance of WASH in trachoma elimination strategies and the need for the development of standardized approaches to
measuring WASH in trachoma control programs.
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Introduction
Trachoma is the world’s leading cause of infectious blindness,
responsible for visual impairment of an estimated 2.2 million
people, of whom 1.2 million are irreversibly blind [1,2]. Repeated
infection with the bacteria C. trachomatis results in scarring of the
conjunctiva of the upper eyelid that inverts the eyelids (entropion)
leading to eyelashes touching the cornea and conjunctiva
(trichiasis). Abrasions and secondary infections of the cornea then
lead, without preventive surgery, to irreversible blindness [3,4].
Although great progress has been made, the disease remains
endemic in 53 countries, primarily in sub-Saharan Africa, the
Middle East, and Asia [2]. Approximately 334,000 disability-
adjusted life years are currently lost due to trachoma infection [5].
An estimated 229 million people live in endemic areas, including
176 million in Africa, though 80% of the global burden is now
limited to 14 countries [6].
Intensive effort since the founding of the Global Alliance for
Elimination of Blinding Trachoma by 2020 (GET 2020) has led
to considerable reduction in the global burden of trachoma from
84 million cases of active trachoma in 2003 to 21.4 million in
2012 [7–10]. Success of trachoma control has been in part due to
the World Health Organization (WHO)-endorsed SAFE strate-
gy: a simple, low-cost ‘‘surgery’’ for patients with advanced
stages of the disease, treatment with the ‘‘antibiotics’’ azithro-
mycin or tetracycline eye ointment, promotion of ‘‘facial’’
cleanliness, and ‘‘environmental’’ improvement, which encom-
passes promotion of sanitation construction and increased water
access [9].
The World Health Assembly (WHA) in resolution 51.11 has
called for the elimination of blinding trachoma by 2020 [8,9].
Donation of Zithromax (azithromycin) by Pfizer Inc. has enabled
scale-up of efforts to reduce disease burden in relation to these
targets. Annual treatments have increased from 1 million doses in
1998 to 47.8 million doses in 2012 [2] and more than 30 countries
have articulated national trachoma strategies and undertaken
trachoma elimination programs [11]. However, these efforts alone
will not lead to sustainable elimination of blinding trachoma, and
it is widely recognized that scale-up of the full SAFE strategy is
needed to reach 2020 targets [12]. In particular, improvements in
environmental conditions, most notably hygiene and sanitation,
are needed for sustained reductions in disease burden, and no
single tool can be recommended for the F and E components of
SAFE [13,14]. As pointed out by the editors of the Lancet in 2012
in response to the launch of Accelerating Work to Overcome the Global
Impact of Neglected Tropical Diseases and reiterated by key stakehold-
ers in the trachoma control community [15], the inclusion of
water, sanitation, and hygiene as a strategic goal within the global
strategy did not include specific goals or targets [16].
There is a need for increased intersectoral collaboration
between neglected tropical disease (NTD) and water, sanitation,
and hygiene (WASH) sectors, as well as for increased financial
resources for WASH interventions in the context of trachoma
control [17]. However, there is little evidence to support specific
WASH interventions within the SAFE framework. While there
have been successes in integrating WASH into trachoma control
[15], a need remains for empirical guidance on the impact of the F
and E components and for guidance on how to monitor progress.
Recent Cochrane reviews on the environmental improvement
(sanitation) component [18] and on face washing [19] revealed few
rigorous randomized trials. The most recent comprehensive
reviews of the impact of sanitation access and face washing on
trachoma were conducted in 2000 [13,14]. We found no previous
reviews of all facets of WASH on trachoma.
We conducted a systematic review and meta-analysis to quantify
the relationship between WASH exposures and C. trachomatis
infection and active disease. Our purpose was to assess and present
the available evidence in order to inform policy for effective and
cost-effective integration of WASH for trachoma control, as well as
to inform WASH monitoring indicators for trachoma control
programs.
Methods
Search Strategy
We performed a systematic review and meta-analysis of the
literature to address the effects of WASH exposures on infection
and clinical signs of trachoma. We systematically searched
PubMed, Embase, ISI Web of Knowledge, MedCarib, Lilacs,
REPIDISCA, DESASTRES, and African Index Medicus data-
bases with no restrictions on language or year of publication. Our
search was performed through October 27, 2013 with no
restriction of start date. We employed a broad set of search terms,
pairing the term [trachom*] with the following WASH-related
keywords: [clean* fac*], [environment*], [excre*], [face washing],
[facewashing], [faec*], [fec*], [hand washing], [handwashing],
[hygiene], [latrine*], [sanitation], [toilet*], [towel*], [wash cloth*],
[waste], and [water]. In addition, we examined seven previous
reviews pertaining to trachoma and some aspect of WASH
[3,14,18–22], and hand searched the bibliographies of all relevant
publications. Any additional articles found to be pertinent during
this process were included.
Studies were included in the systematic review only if they
measured WASH exposure, trachoma infection, and attempted to
quantify the association between a WASH exposure, condition, or
risk factor on trachoma. All study types were eligible if they met
these inclusion criteria, and we employed no additional exclusion
criteria in our approach. If an article was considered relevant, but
data were not available in the format needed for our meta-analysis,
the corresponding authors were contacted by e-mail and asked to
supply the relevant data. We conducted meta-analyses for specific
exposure-outcome relationships based on available data. Meta-
analyses were conducted in adherence to the PRISMA statement
(Text S1) and the MOOSE guidelines for reporting meta-analyses
of observational studies [23]. Our complete protocol is available in
Text S2.
Selection Criteria and Data Extraction
Articles were selected for inclusion using a two-step review
process. First, the titles and abstracts of all identified studies were
examined, and studies that failed to meet the inclusion criteria
after this step were excluded. Second, two reviewers (MES and
CM) independently examined the full text of potentially relevant
articles using a standard protocol developed by MES and MCF. In
the event of disagreement regarding the eligibility of a study
during this phase, the opinion of a third reviewer (MCF) was
sought, and the parameters of the study’s inclusion were discussed
until consensus was reached.
Once a set of eligible studies was agreed upon, relevant data
were extracted from each study by MES using a standard protocol.
To ensure extraction reliability, CM also extracted data from a
subset of 10% of identified studies, and no discrepancies were
found. Data extracted included a brief description of the study
(e.g., study design, setting, year, and sample size), details of the
study population, and measures of trachoma. Measures of
trachoma included C. trachomatis infection assessed by laboratory
analysis of ocular swabs, most commonly using PCR or ELISA
techniques, and clinical signs of active trachoma. Clinical signs of
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trachoma were diagnosed by trained observers using torchlights
and 2.56 magnifying loupes [24]. In this approach, eyes are
graded according to the WHO simplified grading system and
assigned one or more of the following grades: trachomatous
inflammation-follicular (TF), trachomatous inflammation-intense
(TI), trachomatous scarring (TS), trachomatous trichiasis (TT),
and corneal opacity (CO) [25]. Detailed descriptions of all WASH-
related conditions, risk factors, or interventions were assessed and
coded on the basis of the descriptions in Table 1. Primary WASH
components were defined on the basis of the data available from
the review.
Quality Issues
In order to determine the quality of identified studies, we
developed a set of criteria derived from the GRADE methodology
[26]. Our criteria took into account diagnostic features,
assessment of WASH-related risk factors, study design, and
overall strengths and limitations of the studies. Studies could
obtain an overall score ranging between 21 and +6 points for
each meta-analysis. Studies that employed a rigorous diagnostic
approach (e.g., PCR or other laboratory technique used to assess
infection status) received +1 point, while studies that relied only
upon clinical diagnosis of trachoma through eye examinations
were given 0 points. A study was given +1 point if WASH
conditions were investigated directly by the research team (e.g.,
directly observed the presence of sanitation facility or distance to
water source). However, no point was assigned if this was assessed
using only a questionnaire. Studies with quasi-experimental or
experimental designs were awarded +1 point, while observational
studies were awarded 0 points. Studies that purposively calculat-
ed sample size to address trachoma as a key outcome of WASH
characteristics were awarded +1 point. Studies that attempted to
control for confounding factors were assigned an additional +
1 point. A list of the confounders each study attempted to control
for is available in Text S3. Other strengths and limitations of
each study were assessed, and the study was assigned +1 point for
additional strengths, and 21 points for additional limitations.
MES performed the quality assessment independently and
documented the results in separate tables. All relevant studies
were included in the review regardless of their overall quality
rating. Quality ratings did not affect the meta-analysis or
subsequent summary of effect measures, but help to demonstrate
the overall quality of individual studies and to identify research
gaps. The worksheet used in grading studies for each meta-
analysis is available in Text S4.
Meta-Analysis
We conducted meta-analyses for all WASH-related exposures
for which three or more studies reported comparable odds ratios
(ORs) for the same WASH–trachoma association (i.e., ORs
describing the effect of similarly defined exposures on the same
measure of trachoma). All ORs used in meta-analyses reflected the
results of cross-sectional risk factor analyses. WASH conditions
included sanitation access, sanitation use, distance to water of less
than 1 km, clean face, lack of ocular discharge, lack of nasal
discharge, washing face at least once daily, washing face at least
twice daily, bathing at least once daily, towel use, and soap use.
Data were stratified by clinically relevant trachoma measures: C.
trachomatis infection and the most commonly reported measure of
active trachoma, trachomatous inflammation-follicular and/or
trachomatous inflammation-intense (TF/TI). Reported ORs
served as effect measures. Where a study reported more than
one OR for the same WASH exposure (i.e., one for the entire
population and one for a sub-population), we chose for inclusion
the OR most similar to others in the meta-analysis. When both
unadjusted and adjusted ORs were reported, adjusted ORs were
included in meta-analysis [27], and adjusted ORs are indicated
with asterisks within the forest plots. When ORs were not
reported, they were calculated from 262 contingency tables; ORs
that were calculated using data provided by contacted authors are
indicated as such by a footnote in the forest plot. Findings of those
studies identified in the systematic review, but not included in
meta-analyses were summarized and examined for patterns within
and between WASH subcomponent measures, as recommended
by the Cochrane Collaboration [27].
We used Microsoft Excel (Microsoft Corporation) to conduct
meta-analyses and to develop forest plots [28]. Funnel plots were
utilized to investigate the existence of publication bias [29].
Heterogeneity between studies was determined using Higgins’ I2
and Cochran’s Q-tests [27]. When heterogeneity was moderate to
high (I2.50%), sub-group analyses were performed to identify
potential sources of heterogeneity. Random effects models were
used throughout to enhance generalizability of results [30], and
pooled ORs for the effect of the selected WASH conditions on
trachoma were employed [27]. Associations between WASH
conditions and trachoma were reoriented so that all ORs reflect
the relationship between improved WASH conditions on trachoma
(e.g., all facial cleanliness ORs were converted to reflect the effect
of having a clean face, rather than dirty face, on odds of
trachoma).
Table 1. Summary of literature density results for overall
systematic review.
WASH Exposure Article Count
Water 56
Distance to watera 36
Type of water source 19
Access to water 7
Quantity used for washing 6
Total quantity of water 5
Sanitation 51
Sanitation accessa 38
Sanitation usea 8
Sanitation type 6
Sanitation maintenance 3
Sanitation education 3
Hygiene 62
Facial cleanlinessa 33
Face-washing frequencya 19
Ocular dischargea 14
Nasal dischargea 13
Soap usea 7
Hygiene education 6
Towel usea 6
Bathing frequencya 5
Nose wiping practices 5
Towel sharing 3
aExposures with sufficient number of comparable measures of effect to warrant
a meta-analysis.
doi:10.1371/journal.pmed.1001605.t001
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Results
Characteristics of Identified Studies
Our initial search yielded 5,425 publications (Figure 1). Ninety-
nine publications were deemed relevant after review of titles and,
when available, abstracts. These articles were fully screened by
MES and CM. Following this screening, 86 articles were
determined to meet systematic review inclusion criteria
(Tables 2–8). We conducted a total of 15 meta-analyses. A
summary of the calculated pooled ORs and 95% CIs is provided
in Figure 2 and Table 9. Forty-six studies were included in at least
one meta-analysis, and 33 appeared in two or more meta-analyses.
Seventy-six of the included publications were descriptive cross-
sectional surveys, assessing at least one WASH-related condition
or risk factor for C. trachomatis infection or clinical disease; ten
publications involved some WASH-related intervention. Of the
453 effect measures from the included studies, 127 were reported
as adjusted ORs, 269 were reported as unadjusted ORs, 20 were
unadjusted ORs calculated from raw data using 262 tables, and
37 were reported as some other measure of effect (age-
standardized rates, risk ratios, regression coefficients, etc.). Tansy
Edwards, Joanne Katz, Jeremy Keenan, Caleb Mpyet, and
Candace Vinke sent raw data in the form of 262 tables in
response to a data request. Eighty percent of the studies were
conducted in Africa, 10% were conducted in Asia, and 10% were
conducted in Latin America. In general, the quality was low for
studies included in the meta-analyses (see forest plots). These
quality scores were due in part to the observational nature of
nearly all studies, as well as the fact that WASH was the primary
exposure of interest in only 32 of the studies.
Definitions of WASH Characteristics
‘‘Sanitation access’’ was generally assessed through interviews or
questionnaires given to household head or child caretaker,
sometimes verified through direct observation of the presence of
a sanitation facility, which typically meant presence of a
household-level, onsite, toilet or latrine facility. Access does not
necessarily take into account use of the facility, which was
generally assessed independently using questionnaires given to the
head-of-household or a child’s caregiver and, in some cases,
verified through observation of indirect sanitation usage indicators
(e.g., the presence of a beaten path to the door of the sanitation
facility or the presence of feces). ‘‘Sanitation type’’ mainly referred
to shared status or the location of a toilet or latrine (within house
versus within compound). Each study assessing ‘‘facility mainte-
nance’’ defined a different method of assessing and grading
maintenance. All ‘‘sanitation education’’ was part of larger
programs that also included a hygiene education component.
Figure 1. Flow chart of publications identified and excluded for this review.
doi:10.1371/journal.pmed.1001605.g001
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The time and distance increments used in examining the effect
of ‘‘distance to water’’ varied from study to study, although the
baseline for comparison was most commonly ,30 min, or within
1 km to source. Because households often estimate distance to
source in terms of travel time, WASH household surveys
commonly equate a 30 min round trip from household to source
(15 min each way) to a distance of 1 km (average walking speed of
4 km/hr) [31,32]. As such, we standardized distance-to-source
and time-to-source metrics where possible, according to this
commonly used conversion, in order to include related ORs in a
single meta-analysis. Similarly, there were no common volume
increments used when evaluating the effect of ‘‘quantity of water
used for washing’’ or ‘‘total quantity of water’’ collected by a
household. The definition of ‘‘quantity of water used for washing’’
also varied by study (e.g., overall volume of water used for washing
for the entire household versus volume used for individual
children). ‘‘Water source type’’ most commonly examined the
relative effects of community-specific water sources (e.g., tap versus
draw-well versus hand-pump versus ‘‘other’’, or indoor plumbing
versus outdoor plumbing, comparing different types of wells, etc.)
or compared ‘‘safe’’ and ‘‘unsafe’’ water sources as defined in each
study. ‘‘Water access’’ as an exposure was poorly defined. In
general, studies measured the presence of some specific water
source within a village or the reported year-round availability of
water.
The definition of ‘‘facial cleanliness’’ varied slightly from study
to study, but generally was defined as the lack of ocular discharge,
nasal discharge, and/or flies on face at the time of clinical
examination. ‘‘Ocular discharge’’ included any discharge in or
surrounding the eye, including ‘‘sleep’’ in eyes, and ‘‘nasal
discharge’’ included any discharge present from the nose. ‘‘Face
washing frequency’’ and ‘‘bathing frequency’’ were assessed using
questionnaires and were most commonly reported as at least once
daily (versus not daily) and at least twice daily (versus only daily or
Figure 2. Summary of meta-analyses examining association of WASH exposures with active trachoma (TF/TI) and C. trachomatis
infection. Circles indicate ORs, while the size of circles represents the number of studies included in the meta-analysis (n). Horizontal lines represent
95% CIs.
doi:10.1371/journal.pmed.1001605.g002
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not daily) for face-washing frequency, and at least once daily
(versus not daily) for bathing frequency. ‘‘Soap use’’ and ‘‘towel
use’’ were also assessed using questionnaires and were reported as
either use or no use. ‘‘Towel sharing’’ was defined as self-reported
towel sharing or the availability of less than one towel per person.
‘‘Nose wiping practices’’ were also self-reported and compared
children who wipe or blow nose using clothing or handkerchief
and those who used neither. ‘‘Hygiene education’’ included both
cross-sectional assessments of exposure or uptake of hygiene
education and interventions involving hygiene education and
promotion, including combined programs that also included
sanitation education.
Literature Density
Studies often examined more than one WASH exposure or
condition and sometimes reported multiple effect measures (e.g.,
incremental measures of distance or face-washing frequency).
Table 1 provides the total number of articles reporting on each
WASH exposure, and Figure 3 shows the distribution of articles
reporting on various combinations of WASH components. Effect
measures, the number of parameters reported in the literature to
compare a WASH exposure and trachoma outcome, are reported
throughout the manuscript.
Water-Related Exposures or Risk Factors
Fifty-eight of the studies identified in our systematic review
reported at least one measure of effect for a water-related exposure
or risk factor on trachoma, with a total 151 reported effect measures
overall. Two intervention studies that improved access to water by
installing water sources were identified; the remaining studies were
observational. Study participants were chosen at random, either at
individual or at household level in 69% of the relevant studies. In 14
studies, all individuals of a particular community, village, or special
population group were enrolled, whereas no selection criteria for
study participation were specified in four studies.
Figures 4 and 5 illustrate the association between distance to
water and TF/TI and C. trachomatis infection, respectively.
Distance to water was reported in 38 publications, with a total
reported 86 measures of effect. We included articles reporting on
,1 km to water (or ,30 min to collect water) in our meta-
analyses [33]. We found no significant association between ,1 km
to water and TF/TI (OR 0.97, 95% CI 0.83–1.11) nor ,1 km to
water and C. trachomatis infection (OR 1.08, 95% CI 0.86–1.30).
Meta-analyses were not performed for other water-related
conditions or risk factors owing to the lack of sufficient number of
studies with comparable ORs and the variation in how exposures
were measured and defined across studies (e.g., the type of water
source reported in a study varied depending on context, and there
were no common increments in measuring quantity of water
collected or used for washing). The components for which meta-
analyses were not conducted included: type of water source (20
articles, 37 effect measures), access to water (seven articles, seven
effect measures), total quantity of water used for washing (six
articles, 16 effect measures), and total quantity of water used daily
within a household (six articles, nine effect measures). Despite the
Table 9. Summary of meta-analyses examining association of WASH exposures with active trachoma (TF/TI) and C. trachomatis
infection.
WASH Exposure Active Trachoma (TF/TI) C. trachomatis Infection
n
Random Effects Pooled OR
(95% CI) I2 (95% CI) n
Random Effects Pooled OR
(95% CI) I2 (95% CI)
Distance to water #1 km 12 0.97 (0.83–1.11) 77 (60–87) 4 1.08 (0.86–1.30) 0 (0–85)
Sanitation access 26 0.85 (0.75–0.95) 75 (70–86) 7 0.67 (0.55–0.78) 0 (0–71)
Sanitation use 6 0.86 (0.57–1.15) 64 (12–85) — — —
Clean face 25 0.42 (0.32–0.52) 78 (69–85) — — —
No ocular discharge 10 0.42 (0.23–0.61) 68 (37–83) 4 0.40 (0.31–0.49) 0 (0–85)
No nasal discharge 9 0.62 (0.52–0.72) 30 (0–68) 4 0.56 (0.37–0.76) 8 (0–86)
Washes face$once daily 6 0.76 (0.57–0.96) 70 (31–87) — — —
Washes face$twice daily 8 0.85 (0.80–0.90) 0 (0–68) — — —
Bathes$once daily 4 0.76 (0.53–0.99) 60 (0–87) — — —
Uses towel 4 0.65 (0.53–0.78) 40 (0–80) — — —
Uses soap 6 0.76 (0.59–0.93) 48 (0–79) — — —
doi:10.1371/journal.pmed.1001605.t009
Figure 3. Publications reporting on the association between
trachoma and water, sanitation, and hygiene exposures.
Created using eulerAPE software.
doi:10.1371/journal.pmed.1001605.g003
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high number of water source-related studies identified, no meta-
analyses were conducted because water source types tended to be
poorly defined, and individual studies generally examined the
relative effects of site-specific water sources, making comparison of
across studies difficult. No clear significant effect of water source
type was found across the articles, but, in general, those that
showed a significant association between water source and
trachoma found that ‘‘safer’’ water sources (those defined as ‘‘safe
or protected’’ or piped water versus various types of wells versus an
unprotected source) were protective against trachoma. ‘‘Access to
water’’ was defined as either the presence of an improved water
source or self-reported access to water year-round versus
sporadically; most effect measures assessing access to water were
not statistically significant (four effect measures), but those did find
a significant effect suggest improved access is protective (three
effect measures). Additionally, neither intervention that included
the component improving water access led to a significant
reduction in trachoma. Seven reported ORs suggest that using
more water for washing is associated with significantly lower odds
of trachoma, but the remaining nine reported ORs did not show a
statistically significant relationship. Four of six studies reported a
significant association between increased total quantity of water
and lowered odds of trachoma. One study determined that,
regardless of total water collection, using a higher proportion of
the total household water for hygiene is protective [34].
Sanitation-Related Exposures or Risk Factors
Fifty-six of the studies identified in our systematic review
reported at least one measure of effect for a sanitation-related risk
factor on trachoma, with a total of 96 reported effect measures
overall. Four of these studies involved interventions to improve
sanitation or sanitation/hygiene promotion; the remaining studies
were observational. Study participants were chosen at random,
either at individual or at household level in 68% of relevant
studies. In 17 studies, all individuals of a particular community,
village, or special population group were enrolled, whereas no
selection criteria for study participation were specified in one study.
Figures 6 and 7 illustrate the association between sanitation and
trachoma. We found that access to sanitation was associated with
lower trachoma as measured by presence of TF/TI (OR 0.85,
95% CI 0.75–0.95) and C. trachomatis infection (OR 0.67, 95% CI
0.55–0.78). TF/TI was not significantly lower for those that
reported higher levels of sanitation use (OR 0.86, CI 95% 0.57–
1.15) (Figure 8).
Meta-analyses were not performed for other sanitation-related
conditions or risk factors owing to a lack of sufficient number of
studies with comparable ORs and the variation in how exposures
were measured and defined across studies (e.g., there was no
standard definition of either ‘‘facility maintenance’’ or ‘‘sanitation
type’’). These exposures included sanitation type (six articles, 11
effect measures), sanitation education (three articles, six effect
Figure 4. Meta-analysis examining the association of distance to water (#1 km) with TF/TI. Circles indicate ORs, while the size of circles
represents the sample size. Horizontal lines represent 95% confidence intervals. The diamond and corresponding line represent the random effects
pooled OR and 95% confidence interval. *OR was adjusted for possible confounders. {OR was calculated using data sent from author.
doi:10.1371/journal.pmed.1001605.g004
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measures), and facility maintenance (three articles, five effect
measures). One study found the presence of a sanitation facility
within the house to be significantly protective against TF/TI
compared to facilities located outside of the house [35], and
another found that a facility with no privacy may be associated
with increased odds of TF [36]. The remaining four studies found
no association between type of sanitation and trachoma. Three
studies examined the effect of sanitation education or promotion
on trachoma, but these analyses were part of larger programs also
addressing hygiene and face washing, thus sanitation education
could not be isolated. Two of three studies showed FE combined
education intervention villages had significantly lower trachoma at
follow-up. One study examined the effect of sanitation promotion
without hygiene education but found no statistically significant
effect [37].
Hygiene-Related Exposures or Risk Factors
Sixty-four studies identified in our systematic review reported
some association between a hygiene-related exposure and tracho-
ma, with a total of 213 reported measures of effect. Six studies
assessed the effect of a hygiene education intervention on
trachoma; all other studies were observational. Study participants
were chosen at random, either at individual or at household level
in 61% of relevant studies. In 23 studies, all individuals of a
particular community, village, or special population group were
enrolled, whereas no selection criteria for study participation were
specified in two studies.
Facial cleanliness status was reported in 35 publications, with a
total reported 49 measures of effect. We found that having a clean
face was protective against TF/TI (OR 0.42, 95% CI 0.32–0.52)
(Figure 9). No ocular discharge at the time of examination was
associated with reduced odds of both TF/TI (OR 0.42, 95% CI
0.23–0.61) (Figure 10) and C. trachomatis infection (OR 0.40, 95%
CI 0.31–0.49) (Figure 11). We also found significant associations
between lack of nasal discharge and reduced odds of both TF/TI
(OR 0.62, 95% CI 0.52–0.72) (Figure 12) and C. trachomatis
infection (OR 0.56, 95% CI 0.37–0.76) (Figure 13). The relation-
ship between TF/TI and face washing at least once a day (OR 0.76,
95% CI 0.57–0.96) (Figure 14) was stronger than the relationship
between TF/TI and washing at least twice a day (OR 0.85, 95% CI
0.80–0.90) (Figure 15), and soap use was significantly associated
with reduced TF/TI (OR 0.76, 95%CI 0.59–0.93) (Figure 16). Few
studies reported measures of effect between TF/TI and bathing at
least once a day (OR 0.76, 95% CI 0.53–0.99) (Figure 17) or towel
use (OR 0.65, 95% CI 0.53–0.78) (Figure 18).
Meta-analyses were not performed for other hygiene-related
conditions or risk factors due to a lack of sufficient number of
studies with comparable ORs, often resulting from variation in
how exposures were measured and defined across studies (e.g., the
nose-wiping practices of interest varied from study to study,
hygiene education interventions may or may not have included a
sanitation component). These exposures included towel sharing
(three articles, four measures of effect), hygiene education (six
articles and 12 measures of effect), and nose-wiping practices (five
articles, seven measures of effect). Towel sharing among family
members was not found to be significantly associated with
trachoma in any study. One of two interventions focused solely
on face-washing education reported a significant reduction in
severe trachoma (TI) compared to control villages [38]. Two of the
three interventions that combined hygiene and sanitation educa-
tion components showed a significant reduction in TF/TI in
villages receiving education. All five studies addressing nose-wiping
practices reported significant effects: three studies showed that
using clothing to blow nose is a significant risk factor for some
form of clinical trachoma; the remaining two studies showed
significant associations between handkerchief use and lower odds
of TF/TI, TI, and C. trachomatis infection.
Discussion
Our analysis revealed evidence of an association between
improved WASH conditions and exposures and reduced trachoma
in 11 of the 15 meta-analyses conducted with the available
literature. Pooled estimates of effect for the relationship between a
WASH exposure and clinical trachoma (TF/TI) ranged from
strong effects associated with a clean face (OR 0.42) to little
evidence of an association for distance to water source ,1 km
(OR 0.97). Three of the four meta-analyses assessing trachoma
through PCR found associations between WASH conditions and
lower infection with C. trachomatis. Access to sanitation was strongly
associated with lower levels of trachoma, both TF/TI and C.
trachomatis. The relative strength of the association between
sanitation access and C. trachomatis infection compared to TF/TI
Figure 5. Meta-analysis examining the association of distance to water (#1 km) with C. trachomatis infection. {OR was calculated using
data sent from author.
doi:10.1371/journal.pmed.1001605.g005
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may be due in part to the persistence of clinical signs of trachoma
for some time after infection is eliminated [39]. Only seven studies
reported estimates of the relationship between sanitation use and
TF/TI, and while the meta-analysis suggested an association that
was not statistically significant.
We found the strongest evidence of the association between
hygiene factors and trachoma. Our analyses suggest that the
presence of a clean face, the lack of ocular and nasal discharge,
increased frequency of face washing, towel use, the use of soap,
and daily bathing were all associated with lower odds of trachoma.
Figure 6. Meta-analysis examining the association of sanitation access with TF/TI. *OR was adjusted for possible confounders. {OR was
calculated using data sent from author.
doi:10.1371/journal.pmed.1001605.g006
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The relationship between a clean face and reduced odds of
trachoma was one of the strongest associations. The shared use of
towels, which has long been thought to be a key risk factor in the
transmission of trachoma [40–42], was not found to be
significantly associated with increased risk of trachoma in any of
the identified studies, though too few studies were available to
conduct a meta-analysis. Our meta-analysis suggest that facial
cleanliness and the absence of either ocular or nasal discharge are
highly associated with decreased odds of infection with C.
trachomatis. However, there is a potentially tautological effect, as
trachoma causes inflammation of the eyes, which results in
lacrimation and ocular discharge that contains contagion [43]. It
stands to reason that removing ocular discharge removes
contagion, but ocular discharge itself may also be a symptom of
trachoma, and so ocular discharge and active trachoma are both
risk factors and effects. However, considering the strong associ-
ation between facial cleanliness and nasal discharge and trachoma
infection, our results suggest that health behaviors that result in
Figure 7. Meta-analysis examining the association of sanitation access with C. trachomatis infection. Results reported separately for aThe
Gambia population, bTanzania population. *OR was adjusted for possible confounders. {OR was calculated using data sent from author.
doi:10.1371/journal.pmed.1001605.g007
Figure 8. Meta-analysis examining the association of sanitation use with TF/TI. *OR was adjusted for possible confounders. {OR was
calculated using data sent from author.
doi:10.1371/journal.pmed.1001605.g008
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clean faces may reduce the prevalence of trachoma. Our meta-
analysis examining daily face-washing practices suggests that
washing once a day may decrease odds of TF/TI, although
washing more than once a day does not appear to result in an
additional decrease. The use of soap was associated with lower
levels of trachoma, which is particularly relevant as current
strategies for trachoma control advocate for face washing with
water, but do not consistently emphasize the use of soap [41].
Our analysis did not reveal any evidence of an assocation
between the distance to drinking water source and C. trachomatis
infection or TF/TI. The lack of an observed effect may be due in part
to the 1 km cutpoint used in most studies, which may not be
a meaningful standard with respect to trachoma control. A
more proximate drinking water source may serve as an indicator
for increased quantity of water [32], but is not a guarantee of
improved water quality [44]. Given the strong association
found between hygiene and trachoma, a lower cutoff value for
distance to water source, which ensures more assuredly adequate
water quantity for household uses, may be preferable. We found
a number of studies that reported an association between improved
water quantity and reduced odds of trachoma, but there was an
insufficient number of articles to conduct a meta-analysis. Data on
water access were limited by lack of standardization of definitions
and metrics and the resulting low comparability across studies.
Figure 9. Meta-analysis examining the association of clean face with TF/TI. *OR was adjusted for possible confounders.
doi:10.1371/journal.pmed.1001605.g009
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Our review identified relationships between WASH conditions
and trachoma that require additional research. While we found
several studies assessing the association of household sanitation
access and facial cleanliness on signs of trachoma, there are
comparatively fewer exploring the relationship between water use
and trachoma, as well as other characteristics of sanitation, such as
maintenance of sanitation facilities and use of facilities shared by
more than one household. As a result, the association of these
variables with trachoma and the potential role of these variables in
trachoma control remains unknown.
Strengths and Limitations
We searched three widely used databases—EMBASE, Web of
Science, and PubMed—as well as MedCarib, Lilacs, REPIDISCA,
Figure 10. Meta-analysis examining the association of no ocular discharge with TF/TI. *OR was adjusted for possible confounders. {OR
was calculated using data sent from author.
doi:10.1371/journal.pmed.1001605.g010
Figure 11. Meta-analysis examining the association of no ocular discharge with C. trachomatis infection. *OR was adjusted for possible
confounders. {OR was calculated using data sent from author.
doi:10.1371/journal.pmed.1001605.g011
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DESASTRES, and African Index Medicus using a pre-specified,
systematic search protocol. In addition, we hand-searched the
bibliographies of available reviews. We adhered to the MOOSE
guidelines for reporting meta-analysis of observational studies. The
lack of standard definitions and methods of measuring WASH
components in the available studies made meta-analysis for certain
exposures infeasible. In addition, variations in the definitions and
methods could have introduced error in our meta-analyses. Study
design and setting varied, and heterogeneity was moderate to high
in some meta-analyses, particularly those examining the relation-
ship between WASH and TF/TI (refer to I2 values and 95%
confidence intervals in Table 9). Although infection with C.
trachomatis is a more objective measure of trachoma and is likely
associated with more temporal access to WASH, it was the outcome
of interest in only four of our 15 meta-analyses, as most studies
reported only on clinically evident signs of TF/TI, which could be
the result of past infection and more related to cumulative exposure
to risk factors. Overall, funnel plots did not appear to show high
publication bias (Figure S1). However, it is clear from our review
that the majority of studies that report on trachoma prevalence do
Figure 12. Meta-analysis examining the association of no nasal discharge with TF/TI. *OR was adjusted for possible confounders. {OR was
calculated using data sent from author.
doi:10.1371/journal.pmed.1001605.g012
Figure 13. Meta-analysis examining the association of no nasal discharge with C. trachomatis infection. *OR was adjusted for possible
confounders. {OR was calculated using data sent from author.
doi:10.1371/journal.pmed.1001605.g013
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not report on associations with WASH. Many studies only reported
the statistically significant ORs from multivariable analysis. In these
cases, ORs available from the univariable were used in meta-
analyses; however, as these univariable ORs are not adjusted for
possible confounders, they may not be as reliable as ORs from
multivariable analyses. It is difficult to draw solid conclusions for
those WASH exposures for which meta-analyses were not possible
due to scarcity of literature (e.g., facility maintenance and quality,
Figure 14. Meta-analysis examining the association of washing face $1 time per day (versus ,1 time per day) with TF/TI. *OR was
adjusted for possible confounders.
doi:10.1371/journal.pmed.1001605.g014
Figure 15. Meta-analysis examining the association of washing face $2 times per day (versus ,26 per day) with TF/TI. *OR was
adjusted for possible confounders.
doi:10.1371/journal.pmed.1001605.g015
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water source type), and we could be missing important insights into
the relationship between trachoma and other aspects of WASH.
Finally, there is a lack of independence between our meta-analyses
estimates, since many studies report multiple measures of effect that
contribute to several analyses.
All studies included in meta-analyses had relatively low quality
scores. These low-quality grades were due in part to the fact that
only observational studies were included in the meta-analyses, and
all ORs reflected cross-sectional data. WASH exposures were
often assessed as secondary risk factors of interest (e.g., sanitation
access could be included in a model focused on assessing an
antibiotic intervention), meaning that there is a potential for
publication bias if non-significant associations were not included in
final published manuscripts.
We found many different measures of WASH exposures and
many of these parameters were poorly described in the methods. This
lack of specificity and standardization of measures limits the
harmonization of findings into a meta-analysis; this creates challenges
to amassing a consistent and useable body of evidence, and effectively
demonstrating impact across the WASH and disease control sectors.
In addition, we only reported measures of TF/TI together. Since
TI has been dropped from some surveys in recent years, our measures
of effect may represent small differences in the definition of the
outcome.
Policy Implications
While there has been considerable progress in global access to
improved drinking water supply, specifically in East and South
Asia, there is evidence that these gains have systematically ignored
the poorest and most marginalized populations [45,46], which are
precisely the most vulnerable to trachoma. In addition, the world
is far from achieving the Millennium Development Goal target of
reducing by half the global population without access to sanitation.
In sub-Saharan Africa, which has the world’s highest burden of
trachoma, fewer than 50% of households have access to an
improved sanitation facility, and more than 25% of households
Figure 16. Meta-analysis examining the association of towel use with TF/TI. *OR was adjusted for possible confounders.
doi:10.1371/journal.pmed.1001605.g016
Figure 17. Meta-analysis examining the association of soap use with TF/TI. *OR was adjusted for possible confounders.
doi:10.1371/journal.pmed.1001605.g017
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practice open defecation [47]. If elimination of trachoma is to be
achieved, additional resources must be targeted towards sustain-
able access to WASH in trachoma endemic areas. Recent
discourse between the neglected tropical disease (NTD) control
programs and those in the WASH sector may lead to more
tangible efforts at collaboration, coordination, and cooperation
between the sectors [17], which are essential to achieving
articulated WASH strategies, and targeted WASH implementa-
tion for trachoma reduction [12].
Face washing has long been an elemental component of the
SAFE strategy. Among NGOs not specifically targeting trachoma
control, however, improving WASH access is typically promoted
to reduce diarrheal diseases, and as such few promote face washing
alongside handwashing with soap. Our data support the impor-
tance, found by others, of daily face washing to reduce trachoma.
Increasing attention to and investment in improved hygiene
practices that include daily face washing will support the
achievement of trachoma control and elimination targets.
Access to household sanitary facility is an important factor in
trachoma, and continued use of program indicators that record
progress toward improving household access to sanitation is
recommended. Though sanitation use, in addition to access, is
theoretically important to control trachoma, our review found no
significant association between measures of sanitation use and
trachoma. This may suggest that current measures of sanitation
use, which vary between observation of sanitation characteristics
and direct household surveys related to defecation practices, are
not sufficiently accurate or consistent on the whole. Additionally,
despite a scarcity of literature examining the role of sanitation
facility quality or maintenance, interventions to improve the
usability and acceptability of existing sanitation facilities may be
effective. Further research is needed to understand whether
sanitation access at a household level, or whether reaching high
sanitation coverage within the community as a whole is more
important to achieving trachoma reduction. None of these studies
focused on schools, revealing a gap in the literature of the
importance of school-based WASH promotion.
Conclusions
Our review finds that the F and E components of the SAFE
strategy—specifically face washing, facial cleanliness, and sanita-
tion access—but also general hygiene behaviors for trachoma
control are well supported by evidence. Facial cleanliness and
environmental improvement are, in general, highly associated with
trachoma infection and disease. Lack of evidence of the association
between water access and trachoma may be due to the low
number of studies available or a parameterization of water access
(,1 km distance to source) in a majority of studies that does not
best capture the impact of increased access to water for hygiene
and cleanliness. These data support the need for a more
harmonized approach to monitoring WASH exposures as they
relate to trachoma, better monitoring and reporting of these
associations, and increased attention to and funds for the use of
WASH to meet trachoma elimination targets as part of the full
SAFE strategy. Further studies should employ WASH definitions
compatible with those used in the WASH sector, such as the Joint
Monitoring Program definitions for improved and unimproved
water sources and infrastructure [47]. There is, furthermore, a
clear need for more robust evidence of WASH impact on
trachoma that may be achieved by including baseline and
follow-up measurements of trachoma in impact evaluations of
WASH programs and activities.
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Editors’ Summary
Background. Trachoma is a bacterial eye infection, which if
left untreated may lead to irreversible blindness. Repeated
infections over many years cause scarring on the eyelid,
making the eyelashes turn inward. This causes pain and
damage to the cornea at the front of the eye, which
eventually leads to loss of vision. The disease is most
common in rural areas in low-income countries, specifically
sub-Saharan Africa. It spreads easily through contact with the
discharge from an infected eye or nose, by hands, or by flies
landing on the face. Women and children are more often
affected than men. Trachoma is the world’s leading cause of
preventable blindness. A global alliance, led by The World
Health Organization, is aiming to eliminate trachoma by
2020 by adopting the SAFE strategy. There are four
components of this strategy. Two relate to treating the
disease—‘‘surgery’’ and ‘‘antibiotics.’’ The other two compo-
nents relate to long-term prevention by promoting ‘‘facial’’
cleanliness and ‘‘environmental’’ changes (for example
improving access to water and sanitation or reducing the
breeding grounds for flies).
Why Was This Study Done? The SAFE approach has been
very successful in reducing the number of people with
trachoma from 84 million in 2003 to 21.4 million in 2012.
However, it is widely recognized that efforts need to be
scaled up to reach the 2020 goal. Furthermore, if current
improvements are to be sustained, then more attention
needs to be given to the ‘‘F’’ and ‘‘E’’ elements and effective
prevention. This study aimed to identify the most effective
ways to improve hygiene, sanitation, and access to water for
better trachoma control, and to find better ways of
monitoring progress. The overall goal was to summarize
the evidence in order to devise strategic and cost-effective
approaches to trachoma prevention.
What Did the Researchers Do and Find? The researchers
conducted a systematic review, which involved first identi-
fying and then assessing the quality of all of the research
published on this topic. They then carried out a statistical
analysis of the combined data from these studies, with the
aim of drawing more robust conclusions (a meta-analysis).
The analysis involved 15 different water, sanitation, and
hygiene exposures (either hardware or practices, as deter-
mined by what was available in the literature) to determine
which had the biggest impact on reducing the levels of
trachoma. Most of the data came from studies carried out in
Africa. The findings suggested that 11 of these exposures
made a significant difference to the risk of infection or
clinical symptoms of the disease. Improving personal
hygiene had the greatest impact. Effective measures includ-
ed face washing once or twice a day, using soap, using a
towel, and daily bathing. Similarly, access to a sanitation
facility, rather than open ground, also had a positive impact.
The researchers also analyzed the data relating to water
access. However, the studies so far have not yet measured
this in a way that addresses the issues relevant to trachoma
infection. Most studies have looked at whether the distance
from a water source has an impact (and it seems it does not),
whereas it may be more important to assess whether people
have access to clean water or to enough water to wash.
Many of these analyses require additional research to further
clarify the impact of individual water, sanitation, and hygiene
exposure on disease.
What Do These Findings Mean? Overall, the results
support that notion that water, sanitation, and hygiene are
important components of an integrated strategy to control
trachoma. Based on the research available to date, the two
most effective ways are face washing and having access to a
household-level sanitation facility, typically a simple pit
latrine. The findings also point to ways in which current
policy could be improved. Firstly, public health guidance
should be placing greater emphasis on keeping the face
clean. Current advice tends to focus on washing with clean
water, but use of soap appears more effective. There are also
opportunities for organizations to collaborate in this area.
For example, organizations focusing on the prevention of
diarrhea in children, which promote handwashing, could at
the same time campaign for face washing to reduce
transmission of trachoma. The second policy area to target
is access to good quality sanitation. Such policy initiatives
need to be better resourced in countries where trachoma is a
problem. For example, although sub-Saharan Africa has the
world’s highest burden of trachoma, more than 50% of
households there still do not have access to any sanitation
facility.
There were a number of limitations to this study, which may
affect the strength of the conclusions. The researchers found
that many studies on this topic were observational, meaning
that they did not assess an intervention and employ a
control group, thus they are of limited rigor for assessing the
impact of a water, sanitation, and hygiene intervention on
trachoma. There was also a lot of variation in the way that
different studies had defined and measured improvements
to water, sanitation, and hygiene access. This made it difficult
to make comparisons. Standard methods and indicators
need to be developed for this purpose. The study also
highlighted gaps in the research. More work is required to
determine precisely what is needed in terms of access to
water to reduce the incidence of trachoma. Similarly, in
terms of improving sanitation, it is still unclear whether
ensuring every household has a simple, onsite facility would
be more effective than providing clean communal facilities.
The potential role of schools in promoting relevant public
health measures also needs investigation.
Additional Information. Please access these Web sites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001605.
N WHO provides information on trachoma (in several
languages)
N The US Centers for Disease Control and Prevention provide
information on trachoma
N International Trachoma Initiative is dedicated to the goal
of elimination of blinding trachoma
N The Carter Center: Trachoma Control Program has a
Trachoma Health Education Materials Library
N WASHNTD has an online manual resource for NTDs for
WASH policy and programming
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